Results 101 to 110 of about 75,961 (168)

Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

open access: yesGynecol Oncol Rep
Iugai S   +9 more
europepmc   +1 more source

Placement of delayed absorbable mesh to prevent herniation following left diaphragm peritonectomy during ovarian cancer cytoreduction

open access: yesGynecologic Oncology Reports
Background: In the management of advanced ovarian cancer, complex surgery is often necessary to achieve the goal of complete gross resection. Diaphragm resections and intrathoracic procedures are safe and feasible in select patients with advanced ovarian
Ryan M. Kahn, Dennis S. Chi
doaj  

Fluorescence-Guided Surgery to Detect Microscopic Disease in Ovarian Cancer: A Systematic Review with Meta-Analysis. [PDF]

open access: yesCancers (Basel)
Erdemoglu E   +6 more
europepmc   +1 more source

Fluorescence guided total robotic parietal peritonectomy, cytoreductive surgery and closed HIPEC

open access: yesUrology Video Journal
Introduction and Objectives: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is increasingly used for peritoneal surface malignancies, shifting from open to minimally invasive approaches for lower Peritoneal ...
Somashekhar SP   +8 more
doaj  

Efficacy and Insights from an Extensive Series of Cytoreductive Surgery for Peritoneal Neoplasms: A High-Volume Single-Center Experience. [PDF]

open access: yesCancers (Basel)
Aulicino M   +13 more
europepmc   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases at an Australian centre. [PDF]

open access: yesWorld J Surg Oncol
Hayler R   +6 more
europepmc   +1 more source

Isolated Liver Recurrence After Cytoreduction in High-Grade Serous Ovarian Carcinoma: Experience of a Tertiary Center in Turkey. [PDF]

open access: yesJ Clin Med
Koca Yıldırım HE   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy